New Video Presentation
Presented in October, 2017 at the Liquid Biopsies and Minimally Invasive Diagnostics conference, this presentation discusses the evolution of liquid biopsy as a clinical option, how it can deliver uniquely informative data, and how the RareCyte platform provides a highly reliable and efficient basis for liquid biopsy sample processing.
Our Next Conference
Molecular Medicine Tri-Con 2018
February 11-16, 2018
San Francisco, CA
Booth No. 632
Circulating Rare Cell Biomarkers for Immuno-Oncology
Eric Kaldjian, CMO, RareCyte, Inc.
Tuesday, February 13, 3:40PM